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Recurrence of bladder cancer can occur repeatedly in the same patient after treatment of the primary tumor. Models predicting the risk of a next recurrence may inform individualized decision-making on surveillance frequency. We aimed to assess the usefulness of extensions of the Cox proportional hazards model for repeated events in this context. We analyzed 531 Dutch patients with bladder cancer (1990-2012) with information on 7 prespecified predictors at the time of diagnosis of the primary and recurrent tumors. We considered 3 aspects of model variants: how to model time to the repeated events (calendar time, gap time, elapsed time); the number of preceding events (predictor, stratum variable); and the within-subject correlation (ignored in a simple Cox model, robust standard errors in a variance-correction model, random effect in a frailty model). First to fourth recurrences of bladder cancer occurred in 313, 174, 103, and 66 patients, respectively, with median calendar follow-up times of 1.1, 2.5, 3.8, and 4.5 years, respectively. We focused on gap time in the detailed analyses, allowing for clinically meaningful predictions. Variance-correction models may be useful if predictor selection is part of the model development. Frailty models may be useful when within-subject correlation is strong. bladder cancer; Cox proportional hazards model; prediction; prognosis; recurrent events; survival data Abbreviations: AG, Andersen-Gill; NSF, nonstratified frailty; PWP, Prentice-Williams-Peterson.
Prognostic models are increasingly used to predict the risk of future events in individual patients (1, 2) . In several diseases, patients can suffer from repeated events of the same type, such as multiple cardiovascular events (3) or multiple recurrences of cancer (4) . Single event times are typically analyzed using the Cox proportional hazards model. To apply this model to repeated event times, 3 issues need to be considered. First, there are multiple time periods during which a patient can be considered to be at risk of an event. These risk intervals can be defined in different ways. Second, a patient can have 1 or more preceding events that can be modeled either as a covariate or as a stratum variable. Third, the events from the same patient share the same information to some extent, resulting in correlated event times within the patient.
The above issues have been addressed statistically through proposals to extend the Cox model for repeated-event data (5) . The extended models have mainly been used in studies estimating treatment effects (6) and predictor effects (7) , which assessed relative risks such as hazard ratios. However, when predicting repeated events, absolute risks are of interest to support individualized decision-making. For example, patients with bladder cancer may experience multiple recurrences, and those at high risk of a recurrence may benefit from more frequent surveillance. When a recurrence is detected, the time of the next surveillance visit can be updated using the predicted risk of yet another recurrence. To predict the risk of the next recurrence, time-to-first-event Cox models are commonly used, rather than consideration of all possible recurrences in that patient in an extended Cox model (8, 9) . Random-effects models, such as shared frailty models, may give more accurate individual predictions, but the potential application in prognostic research for repeated-event data needs further study.
We aimed to determine the usefulness of extensions of the Cox model for prediction in repeated-event survival data.
Our main focus was on implications for clinical practice. Therefore, we present results from a case study of prediction of recurrences in bladder cancer, a disease where recurrent events are common (10) . We compared the predictive performance of the extended Cox models in empirical and simulated data. Further, we investigated the gain derived from using the extended models instead of simple Cox models that do not account for the repeated-event data structure.
METHODS
We first describe the Cox proportional hazards model for time-to-event data. Next, we consider the following issues in repeated-event data analysis: risk intervals, preceding events, and within-subject correlation. We describe 4 extended Cox models that handle these issues and illustrate the models with data from a bladder cancer study (Table 1) .
Cox proportional hazards model
When patients can experience a single event, the risk interval is defined from a starting point t 0 to the time of the event or the time at which the patient is censored. The starting point t 0 can be time of diagnosis, for instance. The Cox model is frequently used to analyze single-event survival data (11) . This is a semiparametric survival model in that the baseline hazard is unspecified. The proportional hazards assumption states that the predictors act multiplicatively on the hazard, independent of time. The hazard at time point t is equal to the product of the baseline hazard h 0 (t) and the exponent of the linear predictor (βX i ):
where the linear predictor is the sum product of the regression coefficients (β) and the predictor values (X i ).
Issues in repeated-event survival analysis
Risk intervals. Types of intervals that are described in the literature are calendar time, gap time, and elapsed time (Figure 1) (12) . The risk interval for the first event is the same for all 3 definitions. With calendar time, the interval for the next event starts at the time point at which the previous event has ended and the interval ends at the time point at which the next event occurs. The risk intervals with gap time are of the same length as with calendar time, but each interval restarts at zero. For absolute risk prediction, there is an important difference between using calendar time and using gap time. With calendar time, predictions are made only at t 0 -for example, at the primary event, which can (for example) be used in determining a visiting schedule for several years ahead. With gap time, predictions are made for the next event at the time of the current event, which makes it possible to adapt the visiting schedule as more recurrences occur. Risk intervals with elapsed time start at the original t 0 and end at the time point of the related event. Each patient is thus at risk for next events from the original t 0 onwards. This is an unrealistic representation for prediction modeling of a single type of event, and therefore we do not consider elapsed time further.
Preceding events. An earlier event is often informative of the risk of having a next event. The number of preceding events can be taken into account by using it as an additional predictor in the model (13) . The risk curves for the different events are then assumed to be multiples of each other (i.e., proportional), because we use 1 common baseline hazard function h 0 (t) for all events (11) .
If we do not want to assume proportional hazards, a stratified approach can be used in which the shapes of the risk curves are allowed to differ according to the number of preceding events. We can define event-specific baseline hazard functions h 0r (t) by stratifying on the number of preceding events:
As a result, the risk curves of the different events may cross.
Within-subject correlation. The events within a patient are correlated, since the events share characteristics from that patient (5) . If the model is fitted as if all events came from different patients, the correlation is ignored. The regression coefficients will be estimated with too much precision; their variances will be too small. The variance may be post hoc corrected using robust standard errors. These models will be referred to as variance-correction models, and only overall effects can be estimated.
Alternatively, a random effect u i at the patient level can be added to the model, to correct for the smaller effective sample size and condition on the individual patients. For repeated time-to-event data, this random effect is also known as shared frailty. The shared frailty is used to model unobserved heterogeneity between patients, and the individual frailty terms capture the correlations between the event times within patients. A commonly used distribution for the frailty terms is the gamma distribution, with mean 1 and variance θ. The frailty variance reflects the amount of between-subject heterogeneity or, equivalently, the within-subject correlation between event times (14, 15) . The frailty terms are assumed to have a multiplicative effect on the hazard:
The regression coefficients β and their standard errors are estimated conditional on the patient frailties, and therefore patient-specific effects are estimated. The patient-specific effects take into account the fact that some patients may be more prone to experiencing repeated events than others due to unknown patient characteristics (5, 16) .
Survival models for repeated-event data
Based on the modeling decisions regarding handling of preceding events and the within-subject correlation, 4 types of survival models for repeated-event data emerge: 2 variance-correction models and 2 shared frailty models ( Table 1) . Each of these could be combined with either calendar time or gap time.
Two variance-correction models that have frequently been applied in the medical literature are the Andersen-Gill (AG) model and the Prentice-Williams-Peterson (PWP) model. Both models account for the fact that in the presence of correlation between event times within patients, the effective sample size is smaller than the number of analyzed events. Post hoc corrections are applied to the estimated standard errors of the regression coefficients (5) .
The AG model (17) is a nonstratified variance-correction model that was originally used with calendar-time risk intervals. It is used when the order of events is considered unimportant and thus the underlying risks are the same for all events. To relax this assumption, the number of preceding events may be added as a covariate. The PWP model (18) is a stratified variancecorrection model originally used with either calendar-time or gap-time risk intervals. Unlike the AG model, the PWP model considers the order of events to be important and therefore uses the number of preceding events as a stratum variable (11).
Application to bladder cancer case study Patients. We considered patients who were treated for at least 1 nonmuscle invasive bladder tumor between 1990 and 2012 at Erasmus MC-University Medical Center, Rotterdam, the Netherlands. Patient characteristics and characteristics of the first and potential subsequent bladder tumors were extracted from hospital records (10) .
An event was defined as a patient's having recurrent bladder cancer of any stage. Patients were censored when they were still in follow-up at the end of the study, were lost to follow-up, or died from a reason other than bladder cancer. When patients had muscle-invasive progression or radical cystectomy, the event was coded as a recurrence, and follow-up Gap Time Figure 1 . Three definitions of risk intervals during which a patient can be considered to be at risk of an event: calendar time, gap time, and elapsed time. This hypothetical patient has a first event at time t = 0, a second event at t = 6, and so on. A risk interval starts after an event has occurred (not including the time of the event, as indicated by the opening parenthesis) and ends at the time of a new event (including the time of the new event, as indicated by the closing bracket).
was ended from that moment onwards. This way the patient was censored and no longer at risk for a new recurrence. Although we realize that nonmuscle invasive bladder tumors and muscle-invasive tumor progression are clinically different types of events, we considered this difference irrelevant in the methodological example.
When a patient returned to the hospital with a tumor within 3 months after the last tumor had been removed, this tumor was not considered a recurrence but a remainder of the previous one. We considered a maximum of 4 recurrences per patient, to have strata with at least 50 patients.
Our final data set included 531 patients with 656 recurrent tumors. In Table 2 , patient and tumor characteristics are shown for the primary tumor and the first, second, and third recurrences. Tumors were mostly stage Ta, smaller than 3 cm, and not accompanied by carcinoma in situ. The median follow-up time was about 1 year between 2 recurrences, and median follow-up for those without any recurrence was 4.4 years.
Prediction models. Predictors were 2 patient characteristics (age and sex) and 5 tumor characteristics, similar to a previously developed prediction model (4) . Tumor characteristics considered were tumor stage (Ta or T1), tumor grade (1, 2, or 3), tumor size (<3 cm, 3-5 cm, or >5 cm), number of tumors (solitary or multiple), and presence of concomitant carcinoma in situ. Relatively few predictor data were missing. Since our primary aim was to illustrate different extensions of the Cox model, missing data were imputed with single imputation rather than a multiple-imputation procedure (19) .
Prediction models were based on the 4 extended Cox proportional hazards models described in Table 1 . We used only gap-time risk intervals, since these allow for predictions from the time of the previous tumor, which is most relevant for surveillance planning. In the shared frailty models, we applied a gamma frailty distribution with mean 1 and estimated the variance θ. Based on the estimated frailty distribution, we calculated the hazard ratio for the 75th percentile of the individual frailties versus the 25th percentile to indicate within-subject correlation between event times that was not explained by the predictors.
Model performance. To mimic clinical practice, we updated the frailty terms for each patient after each recurrence. When more recurrences have occurred, information is accumulating. The individual frailties can be estimated with the data until that recurrence, using an analytical method with higher-order derivatives of Laplace transforms (20) .
To assess model performance, we considered 2 aspects of internal validity: calibration and discrimination (21) . Reliability of predictions was illustrated for each model with calibration plots per recurrent event. The recurrences of the patients were grouped in quintiles according to their predicted 1-year recurrence risk. For each quintile, the observed 1-year recurrence risk (i.e., the inverted Kaplan-Meier estimate) was plotted against the average predicted 1-year recurrence risk.
To evaluate the discriminative ability of each model, we estimated Harrell's c-index (1). This c-index represents the probability that, for a randomly chosen pair of patients, the patient who experiences a recurrence earlier in time has a higher predicted recurrence risk (22) . The c-indices were estimated within each of the recurrent events (i.e., only events with the same sequence number were paired) at 1 year after the previous event.
We corrected the c-indices for optimism using a bootstrap procedure (200 replications) (23), which we adapted to the repeatedevent structure of our data by drawing bootstrap samples of the patients and including all events occurring in these patients.
Simple Cox models. We fitted 3 Cox regression models not accounting for the correlated data structure: 1) an ordinary Cox model with the number of preceding events included as a covariate, treating all recurrences as if they came from different patients (i.e., an AG model without variance correction); 2) a stratified Cox model with the number of preceding events included as a stratum variable, treating all recurrences as if they came from different patients (i.e., a PWP model without variance correction); and 3) 4 separate Cox models, 1 for each recurrence. For these simple models, we also estimated recurrence-specific c-indices and recurrence-specific calibration plots.
All analyses were performed in R software (R Foundation for Statistical Computing, Vienna, Austria) (24) , with the packages mice, survival, and rms.
RESULTS

Risk intervals
Intervals based on calendar and gap time provide periods at risk that are in agreement with clinical practice, but the interpretations of the related risks differ. A model including calendar time predicts the risk of a new event since t 0 ; a model including gap time predicts the risk of a new event since the previous event. Based on the bladder cancer case study described below, we plotted the recurrence risk over time for the first 4 repeated bladder tumors, to illustrate the difference between gap time and calendar time ( Figure 2 ). Gap time relates to a situation in which another bladder tumor is found and the patient wants to be informed about the risk of having a new bladder tumor within, for instance, 1 year.
Prediction models
First to fourth recurrences of bladder cancer occurred in 313, 174, 103, and 66 patients, respectively ( Table 3) (Table 2 ). This can be partly explained by the higher proportion of progression (23%) at the first event-that is, either radical cystectomy (n = 25), muscle-invasive progression (n = 44), or death from bladder cancer (n = 3). At later events, approximately 12% of the events reflected progression, implying that the lower-risk patients remained in the data set.
The predictor effects were rather similar across the 4 recurrent-event models (Table 4) . A typical finding was the consistently larger 95% confidence intervals for the hazard ratios of the shared frailty models compared with the variancecorrection models (16) . In the nonstratified frailty (NSF) model, the effect of number of preceding events was lower than in the AG model because part of the effect was captured by the frailty term.
The larger-than-zero frailty variances reflect within-subject correlation between event times that is not explained by the predictors (Table 5 ). In the stratified model, the frailty variance was larger than zero only after the third recurrence, suggesting that after the second recurrence the event-specific baseline hazard-defined by stratification-explained more of the withinsubject correlation than the predictor number of preceding events in the nonstratified model (frailty variance = 0.202). Nevertheless, in both frailty models, the hazard ratios for the updated individual frailty terms were all close to 1, indicating that the unexplained within-subject correlation in this data set was quite small.
The predicted 1-year recurrence risks were fairly similar for the nonstratified variance-correction (AG) model and the . The frailty models showed a similar pattern when nonstratified models were compared with stratified models (not shown). The nonstratified variance-correction (AG) and nonstratified frailty (NSF−) models varied in their predictions from the second recurrence onwards (Figure 3, second row) . The stratified models showed a similar pattern when variance correction was compared with shared frailty (not shown). As from the third recurrence, the NSF model had a larger range of predicted risks when including the individual frailty terms (NSF+) than without them (NSF−) (Figure 3, third row) . The stratified frailty model showed a similar pattern (not shown).
Model performance
The calibration plots for the AG model, the PWP model, and the NSF model-both without and with the (updated) frailty terms included in the risk calculations-showed very similar results (Figure 4) . Predictions for the first recurrence were close to the ideal line; predictions for other recurrences deviated more, partly because of the small groups. The same held for the stratified frailty model (not shown).
The recurrence-specific discriminative abilities of the 4 models were similar (Table 6 ). This was the case even when the individual frailty terms were used for prediction of later recurrences, consistent with the relatively low frailty variances.
Comparison with simple Cox models
As expected, the ordinary and stratified Cox models had exactly the same predictor effects and similar 1-year baseline hazards as the AG and PWP models (see Web Tables 1 and  2 , available at https://academic.oup.com/aje). Therefore, the c-indices and calibration plots of these simple models were identical to those of the variance-correction models. However, the standard errors of the predictor effects in the simple models were underestimated.
When comparing them with the PWP model, the 4 separate Cox models had different recurrence-specific predictor effects and smaller recurrence-specific 1-year baseline hazards. In addition, the standard errors were larger due to the small patient numbers per recurrence. This uncertainty led to overfitting of the models, reflected by apparent c-indices (0.56, 0.64, 0.60, and 0.61 for the first recurrence to the fourth, respectively) that were larger than those of the PWP model (0.56, 0.63, 0.58, and 0.58, respectively). Correcting the c-indices for optimism showed a larger decrease for the 4 separate models, with corrected c-indices (0.54, 0.62, 0.54, and 0.54) smaller than those of the PWP model (0.55, 0.62, 0.57, and 0.57). The calibration plots of the 4 recurrence-specific Cox models showed better agreement between predicted and observed risks than the calibration plots of the PWP model, but again reflected the fact that the models were somewhat overfitted to the data (not shown).
Simulation
We performed a simulation study to investigate the effects of amount of within-subject correlation and number of events per patient on the usefulness of the frailty model in a prediction setting. Nine settings were studied: Within-subject correlation was either absent (θ = 0.0), weak (θ = 0.3 as in our empirical data set), or strong (θ = 0.9 as seen in the literature, for example (25)); and the maximum number of recurrences was either 5, 10, or 20 in 25% of the patients (see Web Appendix 1 for technical details and Web Appendix 2 for R code).
For each setting, we fitted the AG model, the nonstratified shared frailty model, and Cox models for specific recurrences (i.e., recurrence-specific Cox). Shared frailty model predictions were based on the linear predictor plus the individual frailty term estimated from the observed predictor and outcome values (20) . The performances of the 3 models were compared within each setting with the c-index.
When within-subject correlation was absent (θ = 0.0), the 3 models showed the same discriminative ability ( Table 7) . The setting with weak within-subject correlation (θ = 0.3) and a maximum of 5 recurrences per patient was similar to the empirical example and showed similar c-indices (0.600 for predicting the fifth recurrence with all 3 models). For a higher number of recurrences, the nonstratified shared frailty model showed greater discriminative ability than the other 2 models in settings with weak within-subject correlation.
The difference in discriminative ability between the 3 models was highest in settings with strong within-subject correlation. When the maximum number of recurrences was 20, the nonstratified shared frailty model showed a c-index of 0.645 (for predicting the 10th recurrence) compared with 0.622 for the AG and recurrence-specific Cox models. The AG model and the recurrence-specific Cox model showed almost identical c-indices in each setting. The large number of patients meant that even the recurrence-specific Cox models provided stable estimates of the regression coefficients.
In general, within each of the 3 models, discriminative ability was lower for higher predicted recurrence numbers. As more recurrences occurred, the risk set contained fewer patients with low recurrence risk, making the population in the risk set more homogeneous. As the patients became more alike in terms of their recurrence risk, it became more difficult to distinguish which patient would have a next recurrence first.
We also used the simulated data to compare robust standard errors from the AG model with the naive standard errors of the simple Cox model. As expected, the robust standard errors were generally larger than the naive standard errors for higher within-subject correlation (see Web Table 3 for sex and number of preceding events).
DISCUSSION
We reviewed 3 issues related to the prediction of repeated events with Cox models: how to deal with the definition of risk interval, the number of preceding events, and the within-subject correlation. Gap time is naturally preferred as the risk interval for the analysis of repeated events, when models are used to predict the risk of a new event after a previous one. To take into account the number of preceding events, their sequence number should be included in the model either as a covariate or as a stratum variable. Stratifying by sequence number results in eventspecific baseline hazards that are not required to be proportional. Within-subject correlation can be handled either by post hoc variance correction or by adding shared frailty terms.
Which model is preferred depends on the user's point of view. A statistician may appreciate a model that closely adheres to the correlated data structure. Therefore, the shared frailty model may be preferred for modeling repeated events in patients. A physician desires an easy-to-use model that provides adequate risk predictions for new patients. If a more complicated frailty model does not outperform a more parsimonious variance-correction model, the latter-such as the AG model-may be preferred.
There is an important interpretational difference between the risk predictions of variance-correction models and frailty models. In the variance-correction models, the correlation between the event times within a patient is merely taken into account by adjusting variance estimates post hoc. The population-averaged predictor effects are used to estimate the risk of a new event for a patient with the specific covariate pattern in the average patient population. In the frailty models, on the other hand, the predictor effects are estimated conditional on the patients' frailties. This may lead to different predictor effects, and, in theory at least, a patient-specific risk can be estimated by including the patient's frailty term in the prediction (26) .
In the bladder cancer data, the unexplained within-subject correlation between event times was too small for the individual frailty terms to improve the predictions of next recurrences. We note that we adjusted both for number of previous recurrences and for time since the previous recurrence, which may already have explained a substantial part of the correlation between event times. On the other hand, we recognize that the frailty models might outperform the variance-correction models when predicting events that occur more frequently (e.g., 10 times or more), when the within-subject correlation is stronger and not captured well by variables such as the number of preceding events and time since the previous event. In that case, Abbreviations: AG, Andersen-Gill; NSF, nonstratified shared frailty; RSC, recurrence-specific Cox. a The c-indices were estimated for predicting the risks of the 5th recurrence, the 10th recurrence, and the 20th recurrence.
b Empty cells indicate that the c-index could not be estimated for that situation.
the multiple event times of a patient contain patient-specific information that may be captured better by the frailty term. In addition to the extended Cox models, we fitted 3 simple Cox models not accounting for the correlated data structure. The ordinary and stratified Cox models discriminated between low-risk and high-risk patients equally as well as the variancecorrection models. Therefore, from a practical point of view, these simple models are sufficient for predicting repeated bladder tumors. We recognize that the predictive ability is rather poor, with c-indices around 0.6. Further markers are needed to predict recurrence of bladder cancer (27) .
Our models contained 7 prespecified predictors. Since ordinary and stratified Cox models underestimate the variance of the predictor effects, these models are not appropriate when developing a prediction model using the precision of the effects of candidate predictors in backward stepwise selection procedures or shrinkage procedures such as the least absolute shrinkage and selection operator (LASSO) (28) .
There are at least 3 limitations of our study. First, a recurrent tumor was assumed to occur at the date of the visit on which it was found. However, patients visited their physicians periodically, causing the time points of the repeated tumors to be in fact interval-censored. Parametric survival models could accommodate the interval-censored data, but then distributional assumptions for the outcome variable (i.e., time-to-event) must commonly be made (11) . Given the methodological focus of this paper, we ignored the interval censoring. Second, the outcome "recurrence" was a composite of the events "new bladder tumor," "progression of bladder cancer," and "bladder cancer death." These event types might alternatively be analyzed separately if their recurrence risks have different treatment implications or if the predictor effects are expected to differ (29) . Third, in this methodological example, we did not attempt to include all factors that may be important for the prediction of bladder cancer recurrence, such as treatment (30) , ethnicity (31), or smoking (32).
In conclusion, gap time is preferred when the physician aims to predict the risk of a new event at the time of the current event. During the modeling process, the number of preceding events should be considered, and whether it should be modeled as a predictor or as a stratum variable depends on the data. For predicting bladder events, a simple Cox model not accounting for the correlated data structure could be used, although variance-correction models are recommended when variable selection is involved. When within-subject correlation between event times is substantial, the frailty model may provide the best predictive performance.
